# GliaMed

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gliamed

- Industry: Pharmaceuticals
- Headquarters: San Jose, US
- Website: www.gliamed.com
- Total disclosed funding: $1.3M
- Latest round: Series A (Jul 2, 2008)
- Investors on record: 1

## About

GliaMed, Inc. is a domain name pricing solutions provider that caters to businesses, entrepreneurs, and investors, facilitating efficient domain appraisals within a 24-hour timeframe.Founded in 2001 and headquartered in San Jose, US, GliaMed, Inc. specializes in domain name pricing solutions. The company has undergone no significant pivots or strategic changes since its inception. GliaMed raised USD 1.3 million in Series A funding from Quantum Technology Partners on July 2, 2008, which represents the total amount raised to date, and the company currently holds a valuation of USD 20.206 mn.GliaMed.com offers domain name pricing solutions for a varied clientele, including businesses and individual investors. Clients can receive domain value assessments within 24 business hours by submitting an inquiry form on their website. The company’s domain experts evaluate market value based on relevance and trends, primarily serving customers in the United States and Canada, as well as international clients.GliaMed.com’s revenue model is transactional and focuses on domain name appraisals and sales. Clients engage directly with domain experts, submitting pricing requests that facilitate tailored responses. While specific pricing details for services are not disclosed, it can be inferred that fees exist for domain evaluations and sales facilitated through the platform. The company's revenue generation is primarily supported by its domain valuation service, which connects sellers and buyers.Following the Series A funding round in July 2008, GliaMed intends to leverage the USD 1.3 million raised to enhance its service offerings and expand into new markets. The company aims to develop new products tailored for emerging digital markets and increase its presence in regions beyond the US and Canada, although specific new geographic targets and product release dates have not been articulated.

## Funding rounds

- Series A, Jul 2, 2008, $1.3M — Quantum Technology Partners

## Investors

- Quantum Technology Partners (https://capitalatlas.ai/funds/quantum-technology-partners) — Series A